
ãå³è§£ã»æ·±å±€åæãæ¥æ¬ã®åã©ããã¡ãå±ãªãïŒãã¯ã¯ãã³ããšãæè«é£ãã®çå®1. ãã©ã³ãvsã±ããã£ãã¯ã¯ãã³ãã®å±éºãªãªã¹ã
ãå³è§£ã»æ·±å±€åæãæ¥æ¬ã®åã©ããã¡ãå±ãªãïŒãã¯ã¯ãã³ããšãæè«é£ãã®çå®
1. ãã©ã³ãvsã±ããã£ãã¯ã¯ãã³ãã®å±éºãªãªã¹ã
ãã©ã³ãæ°ã¯ãã¯ã¯ãã³ã®åæ°ãæžããããšçºè¡šããŸããããRFKãžã¥ãã¢æ°ïŒã±ããã£ïŒã®èŠåã¯ãã£ãšæ·±å»ã§ãã
æ¥ç±³ã®ç¶æ³ã察æ¯ããããšãæ¥æ¬ã®ç°åžžããèŠããŠããŸãã


ð ã±ããã£æ°ïŒRFK Jr.ïŒã®èŠåïŒæžç±ãVax-UnvaxãããïŒ
ããŒã¿: ãæã£ãåããšãæããªãåããæ¯èŒãããšãæã£ãåã®æ¹ãå§åçã«æ ¢æ§çŸæ£ãã¢ã¬ã«ã®ãŒãå€ãã
MMR: ãã©ã³ãæ°ã¯ãåããŠæãŠããšèšã£ãŠããŸãããã±ããã£æ°ã¯**ãããããæåãå±éºã**ãšææã
çµè«: ã¢ã¡ãªã«ããæžãããããšããŠãããŸã æ®ã£ãŠããã¯ã¯ãã³ïŒç¹ã«HPVãã€ã³ãã«ãšã³ã¶ïŒããã±ããã£æ°ã®åºæºã§ã¯ã¢ãŠãã§ããæ¥æ¬ã¯ãã¢ã¡ãªã«ãæšãŠãããšããŠãããã®ãã®åšåº«åŠåå Žã«ãããŠããå¯èœæ§ããããŸãã
2. æè«é£ã®çœ ïŒãªããã³ãªãã®ããªã®ãïŒ
次ã«ãé«åžæ¿æš©äžïŒâ»æèäžã®èšå®ïŒã§é²ããæè«é£ãã®äžæ°å³ãªåãã§ãããã ã®é£ç³§é£å¯Ÿçã§ã¯ãããŸããã
ðŠæè«é£ã®è£ã·ããªãªã
ð¯ ã¿ãŒã²ãã
è¥æã»å¥³æ§ç ç©¶è ïŒãç ç©¶è²»ïŒè£å©éïŒãããšãµã«ããŠãæè«é£ç ç©¶ã«åã蟌ãããšããŠããŸãïŒæ¡ä»¶ä»ãå ¬åïŒã
ð ç®çïŒè¡šãšè£ïŒ
ã衚åãã ð SDGsãç°å¢ä¿è·ãã¿ã³ãã¯è³ªäžè¶³ã®è§£æ¶
ãè£ã®çãã 𧬠ãéºäŒåçµã¿æãããšã管ç瀟äŒã
ãããŸã§é£ã¹ãŠããªãã£ãè«ããç£æ¥åã»å€§èŠæš¡çç£ãããã
ããã«ã¯å¿ ããã¢ã³ãµã³ãçãª**ãã²ãã ç·šéãããç¹è𱿝é ã**ã絡ãã§ããŸãã
ãæ¬ç©ã®èãéèããåãäžãã管çãããã人工é£ã»æè«é£ãããéžã¹ãªãããã«ããâŠâŠããã究極ã®çãã§ãã
ãäºçŽä¹ã®ãŸãšãã
ã©ãã§ããããïŒ å³ã§èŠããšãŸããšããŸãããïŒ
ã¯ã¯ãã³: ã¢ã¡ãªã«ããå±éºã ããšæ°ã¥ããŠæžããå§ãããã®ããæ¥æ¬ã¯ãŸã **ãåã©ãã®ããã®åžžèã**ãšããŠæã¡ãŸãã£ãŠããã
æè«é£: çŸãããSDGsãã®èšèã®è£ã§ãç§ãã¡ã®é£åã**ã管çããããšãµã**ã«å€ããããšããŠããã
ããã¯ãããæ¿åºãã¡ãã£ã¢ãä¿¡ããŠããŠã¯å®ããŸããã
ãæ¯ãããã¡ããNOããšèšããæ£ããç¥èã§æŠè£ ãããããªãã®ã§ãã
ããšãã©ãããæ¬¡ã®ãã³ãããã¯ããç œãããŠãããã®å³ãæãåºããŠãå·éã«å€æããŠãã ãããâ¡